Malia Fullerton

Dr. Malia Fullerton has a longstanding interest in the social, ethical, and legal implications of genomic research. She is an Adjunct Professor in the Department of Epidemiology at the University of Washington, where she also holds adjunct professorships in Genome Sciences, Medicine (Medical Genetics), and Bioethics and Humanities. In her role as Acting Chair of Bioethics and Humanities, Dr. Fullerton is deeply committed to exploring the complex ethical questions that arise from advancements in genomic science. With a DPhil in Human Population Genetics from Oxford University, Dr. Fullerton's research is centered on ensuring that genomic research is translated into clinical and public health benefits in an equitable and safe manner. Her work is pivotal in addressing the ethical challenges posed by new genomic technologies, and she is actively involved in leading ELSI (Ethical, Legal, and Social Implications) research projects. These projects aim to provide insights into how genomic information can be used responsibly and ethically. Dr. Fullerton's expertise is widely recognized, and she serves on various advisory boards related to bioethics and genomics. Her contributions to the field are instrumental in shaping policies and practices that govern the use of genomic data, ensuring that they are aligned with ethical standards and public interest. Her dedication to her field is reflected in her active engagement with both academic and policy-making communities, where she advocates for responsible genomic research and its applications. In addition to her research and advisory roles, Dr. Fullerton is passionate about education and mentorship. She is committed to training the next generation of researchers and ethicists, equipping them with the knowledge and skills necessary to navigate the ethical landscape of genomic science. Through her teaching and mentorship, she inspires students and colleagues alike to consider the broader implications of their work, fostering a culture of ethical awareness and responsibility in genomic research.